Back to Results
First PageMeta Content
EDA / Hypodontia / Ectodysplasin A2 receptor / Genodermatoses / Hypohidrotic ectodermal dysplasia / Ectodermal dysplasia


  EDI200 – A Biotherapeutic For Treating X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) Phase 2 clinical study initiated Preclinical data strongly confirms validity of target pathway and therapeutic approach
Add to Reading List

Document Date: 2014-06-05 15:51:36


Open Document

File Size: 759,41 KB

Share Result on Facebook
UPDATE